Published April 17, 2018
| Version v1
Patent
Open
Methods and compositions related to T-cell activity
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
Embodiments concern methods and composition related to anergic T-cells in patients, such as cancer patients. T cell anergy is a hyporesponsive state induced by TCR engagement in the absence of costimulation (Schwartz, 2003). Anergy induction was initially observed in vitro using chemically-fixed antigen presenting cells (APCs). Subsequently, it was found that anergy could be induced by immobilized anti-CD3 mAb or calcium ionophores (such as ionomycin) in vitro, and by superantigen and soluble antigenic peptide in vivo. Indirect evidence has suggested that T cell dysfunction in the tumor microenvironment and establishment of transplant tolerance is partially due to T cell anergy (Gajewski et al., 2011).
Files
US9944992.pdf
Files
(3.9 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:b7ed1291463ff23c0f7f319755b06ff2
|
3.9 MB | Preview Download |
Additional details
Identifiers
- Patent number
- US 9944992 B2
- Patent application number
- US 201414777123 A
- Other
- oai:uchicago.tind.io:8190
Dates
- Patent filed
-
2014-03-14